Clinical Trial: Phase I/ II Study of SCTB41 Plus SCTB39G With or Without Standard Therapy in Advanced Solid Tumours

U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07665970) titled 'Phase I/ II Study of SCTB41 Plus SCTB39G With or Without Standard Therapy in Advanced Solid Tumours' on June 18.

Brief Summary: This study aims to evaluate the safety, tolerability, PK characteristics, immunogenicity, and preliminary anti-tumor efficacy of SCTB41 in combination with SCTB39G with or without standard therapy in adult patients with advanced malignant solid tumours. This study is an open label, multicentre, dose-escalation and dose-expansion Phase I/II clinical trial.

Study Start Date: June 30

Study Type: INTERVENTIONAL

Condition: Advanced Malignant Solid Tumors

Intervention: DRUG: SCTB41+SCTB39G

SCTB41 plus SCTB...